GRIN2A (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2A) encodes the GluN2A receptor subunit that has been shown to act as a tumor suppressor, with mutant forms acting in a dominant negative fashion on the wild-type receptor [27]. The gene discussed is GRIN2A; the disease is neoplasm.